Some DPP4 substrates with CV impact are upregulated in obesity and/or T2DM as well as in COVID-19 such as CXCL5/RANTES and BNP (Niraula et al., 2018; Adela et al., 2019). Here, DPP4 is linked to type 2 diabetes mellitus.